JP2022526624A5 - - Google Patents

Info

Publication number
JP2022526624A5
JP2022526624A5 JP2021559424A JP2021559424A JP2022526624A5 JP 2022526624 A5 JP2022526624 A5 JP 2022526624A5 JP 2021559424 A JP2021559424 A JP 2021559424A JP 2021559424 A JP2021559424 A JP 2021559424A JP 2022526624 A5 JP2022526624 A5 JP 2022526624A5
Authority
JP
Japan
Prior art keywords
composition according
seq
infection
positive bacteria
gram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021559424A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022526624A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/027752 external-priority patent/WO2020210691A1/en
Publication of JP2022526624A publication Critical patent/JP2022526624A/ja
Publication of JP2022526624A5 publication Critical patent/JP2022526624A5/ja
Pending legal-status Critical Current

Links

JP2021559424A 2019-04-11 2020-04-10 骨及び関節の感染を治療及び予防する方法 Pending JP2022526624A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962832754P 2019-04-11 2019-04-11
US62/832,754 2019-04-11
US201962849672P 2019-05-17 2019-05-17
US62/849,672 2019-05-17
US201962938812P 2019-11-21 2019-11-21
US62/938,812 2019-11-21
US202062964755P 2020-01-23 2020-01-23
US62/964,755 2020-01-23
PCT/US2020/027752 WO2020210691A1 (en) 2019-04-11 2020-04-10 Method of treating and preventing bone and joint infections

Publications (2)

Publication Number Publication Date
JP2022526624A JP2022526624A (ja) 2022-05-25
JP2022526624A5 true JP2022526624A5 (enExample) 2023-04-03

Family

ID=72752118

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021559424A Pending JP2022526624A (ja) 2019-04-11 2020-04-10 骨及び関節の感染を治療及び予防する方法

Country Status (11)

Country Link
US (1) US20220193186A1 (enExample)
EP (1) EP3980049A4 (enExample)
JP (1) JP2022526624A (enExample)
KR (1) KR20210151188A (enExample)
CN (1) CN114025783A (enExample)
AU (1) AU2020271116A1 (enExample)
BR (1) BR112021019884A2 (enExample)
CA (1) CA3136461A1 (enExample)
IL (1) IL286994A (enExample)
MX (1) MX2021012375A (enExample)
WO (1) WO2020210691A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023081691A1 (en) * 2021-11-04 2023-05-11 Contrafect Corporation Method of treating and preventing bone and joint infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034322B2 (en) * 2011-04-21 2015-05-19 The Rockefeller University Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
MX389127B (es) * 2012-05-09 2025-03-19 Contrafect Corp Lisina de bacteriófago y combinaciones de antibióticos contra bacterias gram positivas.
ES2729123T3 (es) * 2012-05-09 2019-10-30 Contrafect Corp Rotura de biopelícula con lisina plyss2
RU2754667C2 (ru) * 2016-05-12 2021-09-06 Контрафект Корпорейшн Способ микроразбавления в жидкой среде для оценки и определения минимальной ингибирующей концентрации антибактериальных полипептидов
BR112020017219A2 (pt) * 2018-02-26 2020-12-22 Contrafect Corporation Lisinas plyss2 modificadas e usos das mesmas
JP2021527699A (ja) * 2018-06-22 2021-10-14 コントラフェクト コーポレイション 溶解素及びその誘導体がスタフィロコッカス・アウレウス及びグラム陽性細菌を抗生物質に再感作する

Similar Documents

Publication Publication Date Title
Falagas et al. Linezolid for the treatment of adults with bone and joint infections
Trampuz et al. Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment
Anagnostakos Therapeutic use of antibiotic-loaded bone cement in the treatment of hip and knee joint infections
Zheng et al. The use of BMP-2 coupled–Nanosilver-PLGA composite grafts to induce bone repair in grossly infected segmental defects
RU2010140682A (ru) Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство
CN106456835A (zh) 增材制造制备的抗菌制品
JP2021527699A5 (enExample)
HUP0002662A2 (hu) Lizosztafint magában vagy antibiotikus kombinációban tartalmazó gyógyászati készítmény, amely stafilokokkusz fertőzések kezelésére alkalmazható
König et al. Treatment of staphylococcal implant infection with rifampicin-ciprofloxacin in stable implants
Kühn et al. PMMA bone cement: What is the role of local antibiotics
De Lalla Antibiotic prophylaxis in orthopedic prosthetic surgery
Ahmed et al. Anti-biofilm agents in control of device-related infections
Pioletti et al. Orthopedic implant used as drug delivery system: clinical situation and state of the research
Kazemzadeh-Narbat et al. Antimicrobial peptide delivery from trabecular bone grafts
EP1689405B1 (en) Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance
JP2022525914A5 (enExample)
US20070092572A1 (en) Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
Hyams et al. Serratia endocarditis in a pediatric burn patient: Cure with cefotaxime
Liu et al. Research progress on periprosthetic joint infection after arthroplasty
d'Ettorre et al. Surgical debridement with muscle flap transposition and systemic teicoplanin therapy for infected hip arthroplasty
Frommelt Gentamicin release from PMMA bone cement: mechanism and action on bacteria
RU2021129174A (ru) Способ лечения и предотвращения инфекций костей и суставов
CN114615991B (zh) 作为用于抗微生物剂的佐剂的纤维蛋白原和疗法
RU2779346C2 (ru) Антибактериальные композиции и способы
WO2020210691A1 (en) Method of treating and preventing bone and joint infections